Crossmark

HDAC6-dependent deacetylation of TAK1 enhances sIL-6R release to promote macrophage M2 polarization in colon cancer

Crossref DOI link: https://doi.org/10.1038/s41419-022-05335-1

Published Online: 2022-10-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xu, Guangying https://orcid.org/0000-0002-4722-3557
Niu, Liling https://orcid.org/0000-0002-4938-5517
Wang, Youhui https://orcid.org/0000-0001-9358-0275
Yang, Guang https://orcid.org/0000-0003-1305-4545
Zhu, Xingwu https://orcid.org/0000-0001-8031-9190
Yao, Yuan https://orcid.org/0000-0002-3670-4240
Zhao, Gang https://orcid.org/0000-0002-3851-5216
Wang, Shaowei

Li, Hui https://orcid.org/0000-0002-3526-6664
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82171728, 82171728, 82171728, 82171728, 82171728, 82171728, 82171728, 82171728, 82171728)

Natural Science Foundation of Tianjin Municipal Science and Technology Commission (20JCQNJC00130, 20JCQNJC00130, 20JCQNJC00130, 20JCQNJC00130, 20JCQNJC00130, 20JCQNJC00130, 20JCQNJC00130, 20JCQNJC00130, 20JCQNJC00130)

Natural Science Foundation of Tianjin Municipal Science and Technology Commission

Natural Science Foundation of Tianjin Municipal Science and Technology Commission

Natural Science Foundation of Tianjin Municipal Science and Technology Commission

Natural Science Foundation of Tianjin Municipal Science and Technology Commission

Natural Science Foundation of Tianjin Municipal Science and Technology Commission

Natural Science Foundation of Tianjin Municipal Science and Technology Commission

Natural Science Foundation of Tianjin Municipal Science and Technology Commission

Natural Science Foundation of Tianjin Municipal Science and Technology Commission
License Information

Text and Data Mining valid from 2022-10-21

Version of Record valid from 2022-10-21
More Information

Article History

Received: 28 June 2022

Revised: 4 October 2022

Accepted: 10 October 2022

First Online: 21 October 2022

Competing interests

: The authors declare no competing interests.

: The present study was approved by the local Research Ethics Committee of the Academic Medical Center of Tianjin Cancer Hospital (approval number: Ek2021165), and the Animal Ethical and Welfare Committee of Tianjin Medical University Cancer Institute and Hospital (approval number: NSFC-AE-2021089). Informed consent was obtained in all cases.

Document is current

Any future updates will be listed below